January 2014 The Aging Population

Our round-up of difficult-to-read prescriptions.

Case studies involving urinary incontinence and the appropriateness of high-dose statin therapy.

Our round-up of pharmacy annoyances.

Consuming antioxidants and fish may protect against macular degeneration in individuals who are at a high genetic risk for developing the condition, according to a recent study.

Although taking daily multivitamins may have some health benefits, a recent study suggests that long-term use of supplements does not reduce the risk for age-related macular degeneration.

Macular degeneration patients often have trouble reading, but a new study finds that double line spacing and double word spacing may make reading easier for these patients.

Although eating disorders are assumed to mainly affect teenaged girls, a recent study finds that young men are also preoccupied with body image.

Men who continue to smoke after being diagnosed with cancer are significantly more likely to die than those who quit, according to a recent study conducted in China.

Older men with moderate natural testosterone levels may be more likely to live longer than those with the highest and lowest levels, a new study suggests.

Pharmacists can learn about new drugs approved by the FDA in 2013, including clinical indications, mechanisms of action, interactions, adverse reactions, and dosing guidelines.

Pharmacists can learn about treatment of major depressive disorder.

A case involving a modified medication schedule and a transcription error that may have contributed to a patient's demise.

The FDA recently cleared the way for giving hydrocodone combination products a CII status, so pharmacists should be prepared for the consequences of this potential change.

In the struggle with Alzheimer's disease, pharmacists can provide pertinent information about the associated myths, realities, and symptomatic treatments.

Left untreated, gastroesophageal reflux disease results in significant complications.

The Affordable Care Act prevents any health care plan from excluding coverage for benzodiazepines.

Meaningful federal compounding legislation has been developed.

One in 3 individuals is at risk for developing shingles.

OTC case studies involving overactive bladder, arthritis pain management, sleep aids, and herbal supplement use for memory.

Our round-up of new OTC products.

The struggles of managing rheumatoid arthritis and how pharmacists can help are illustrated through one patient's experience.

The FDA has approved Fetzima (levomilnacipran extended-release capsules) for the treatment of major depressive disorder in adult patients.